Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...

An immune cell type called macrophages, found throughout the body's tissues, are often referred to as the body's clean-up ...

Heart failure (HF) is one of the leading causes of death and disability worldwide, affecting millions of people and placing ...

Uncertainty surrounding how truncated titin proteins (TTNtvs) cause dilated cardiomyopathy (DCM) and peripartum cardiomyopathy (PPCM) led to investigations that could better inform therapies for these ...

Dying from a broken heart may sound dramatic—but it’s very much a real thing. If you’ve ever experienced a heartbreak so ...

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...

Heart failure (HF) has long been blamed on weakened heart muscle cells, but new research shows that support cells called fibroblasts may be a key factor. Researchers found that fibroblasts send ...